biotech firesales Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech firesales

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	10/15/2004 7:36:46 PM
	Read Replies (1) of 3661

Just in case TKTC belongs here Monday morning, this will probably be the reason why... * 18:09 ET Transkaryotic: Court Rules in Amgen's Favor in TKT Litigation (TKTX) 16.79 -0.48: -- Update -- Amgen (AMGN) announces that a U.S. District Court ruled in its favor in the patent litigation suit against Transkaryotic Therapies and Aventis Pharmaceuticals (AVE). The Court found Amgen's patent claims valid and infringed by TKT and Aventis. The result of this decision, coupled with earlier decisions, is that four Amgen patents on erythropoietin have been held valid, enforceable, and infringed.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next